The authors studied mineralocorticoid receptor (MCR)mediated effects of steroids on CD34 + progenitor cells. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis showed the presence of mRNA for both the MCR and the alpha subunit of the epithelial sodium channel, a member of the amiloride-sensitive sodium channel (ASSC) superfamily, in human CD41 + megacaryoblastic cells derived from cultured bone marrow CD34 + isolates, as well as in the human erythromegakaryoblastic leukemia (HEL) cell line. Immunofluorescence also revealed the presence of both the MCR and ASSC in circulating CD34 + and medullar CD41 + megacaryoblastic cells, the former as a nucleocytoplasmic protein and the latter as a membrane-bound protein, as expected from earlier studies using MCR-specific targets. In a selective medium, the formation of erythrocyte burst-forming units, and of the granulocyte-macrophage colony-forming units, by circulating CD34 + cells was influenced by the agonists deoxycorticosterone and aldosterone, as well as by the antagonists RU 26752 and ZK 91587, targeted for the MCR. The multiplication of the leukemic HEL progeny, derived from CD41 + cells, was similarly altered by these steroids targeted for the MCR. In contrast, in the optimal growth medium, the multiplication, and colony formation by bone marrow CD34 + progenitor cells were not altered by either aldosterone or ZK 91587. These and other studies reveal that the receptor-mediated action of mineralocorticoids may influence the functional maturation of the hematopoietic progenitor lineage, contrary to the classical notion where the mineralotropic effect would be a unique feature of the epithelial cell.
tion must continually decide between renewal and multilineage differentiation along a specified molecular pathway (Smithgall 1998; Wessely, Deiner, and Beug 1997) . In hematopoiesis, the pluripotent bone marrow stem cell differentiates, progressively, along the lymphoid and myeloid lineages. Normally, the megacaryocyte lineage gives rise to platelets but altered differentiation could result in the genesis of leukemic cells, such as the human erythroblastic leukemia (Smithgall 1998; Wessely, Deiner, and Beug 1997) . The determining factors that decide among self renewal, programmed differentiation, and abnormal immortalization remain to be elucidated.
Glucocorticoid hormones influence a large variety of processes in almost all types of blood cells, including stimulatory effects on the maturation and functional differentiation of hematopoietic cells (Billat, Felix, and Jacquot 1982; Golde, Bersch, and Cline 1976) , inhibitory effects on the differentiation of murine leukemic cell lines (Kaneda, Murate, and Sheffrey 1995; Udupa, Crabtree, and Lipschitz 1986) , induction of apoptosis (Chang et al. 1993) , and activation of oncogenes (Moalli and Rosen 1994) ; in leukemic cells gonadal steroids are generally cytotoxic (Ashraf and Thompson 1993; Blagosklonny and Neckers 1994) . Leukocytes are endowed with the mineralocorticoid receptor (MCR) (Shimada et al. 1993 ) and murine osteoblastic cells exhibit altered growth response to steroids targeted for specificity to the MCR (Agarwal et al. 1996) . The biological effect of mineralocorticoids, under these conditions, has remained unexplained because they are believed primarily to affect the epithelial sodium channel in target epithelia (Agarwal 1994; Agarwal and Mirshahi 1999; MacKnight, DiBona, and Leaf 1980) . Here, we provide pioneering evidence for the MCRmediated effects in CD34 + progenitors and their derivatives (Krause, Fackler, and Civin 1996; Nilius and Droogmans 2001) . isolated by centrifugation on Ficoll-Hypaque (density 1.077 g/ ml) obtained from Pharmacia, France. Low-density mononuclear cells were washed several times in phosphate-buffered saline (PBS) containing 1 mM EDTA to avoid platelet aggregation, resuspended at a concentration of 5 × 10 6 cells/ml in RPMI 1640 medium supplemented with 10% fetal calf serum, and incubated overnight in plastic culture flasks at 37 • C under 5% CO 2 to remove adherent cells.
Immunomagnetic Purification of CD34 + + Cells
CD34 + cells were recovered from nonadherent cells by the immunomagnetic bead technique according to the recommendations of the manufacturer (Isolation Kit CD34 MACS; Miltenyl Biotec, Tebu, France). For magnetic cell sorter (MACS) separation, CD34 + hematopoietic progenitor cells were indirectly labeled using hapten-conjugated primary monoclonal anti-CD34 + antibody (QBEND-10) and an anti-hapten antibody coupled to submicroscopic magnetic beads. The magnetically labeled cells were purified on positive-selection columns in the magnetic field of the Vario-MACS. This procedure routinely gave >97% viable CD34 + cells (trypan blue procedure), which, when needed, were resuspended in Trizol (Life Technology, Gibco BRL, France) and stored at −80 • C until use.
Cell Immunostaining and Flow Cytometric Analysis
Purified cells were stained with a monoclonal antibody (Dako, France) directed against either CD34 + (8B12 PE) or CD41/ GPIIbllla (5B12 PE) to allow flow cytometric analysis. Multiparametric analysis of the purified cells for cell surface antigen expression was performed on 5×10 4 cells labeled with 10 µg/ml (saturating concentration) of the monoclonal antibody at 4 • C for 15 minutes in 40 µl PBS-2% bovine serum albumin (BSA). The cells were washed twice and analyzed using a Facscalibur (Becton Dickinson). For each sample, 2 × 10 4 events in the list mode consisted of forward light (FS) and side (SS) fluorescence signal scattering that were recorded and analyzed with Cellquest (Becton Dickinson).
Megacaryocyte Liquid Culture
Short-term liquid cultures of megacaryoblastic cells were set up in duplicate wells (2 × 10 5 CD34 + cells/ml) using the Stem-αMK medium containing interleukin (IL)-3, IL-11, and IL-6 (Stemα sarl, Villeneuve Saint Georges, France) and supplemented with 50 ng/ml of thrombopoietin (Peprotech, Tebu, France). On day 12 of the culture, cells were harvested and labeled for CD41 + expression, further purified using MACS method, and finally resuspended in Trizol (Life Technology, Gibco BRL, France) prior to storage at −80 • C until use.
Another set of bone marrow CD34 + cells was grown in the medium MV2 kit (Promo cell, Germany) containing 5% fetal calf serum (FCS), epidermal growth factor, vascular endothelial growth factor, basic fibroblast factor, R3 insulin growth factor-1, ascorbic acid, amphotericin B, and gentamicin. The cells were cultivated for 1 week in the presence of various steroid agonists and antagonists of choice and analyzed for cell multiplication, viability, and morphology. All experiments were carried out in a cell cultivation chamber using sterile materials and reagents; control culture viability was >97% in all cases.
Human Peripheral Blood Progenitor Cell Culture
CD34 + (5 × 10 3 cells/ml) from human peripheral blood, prepared as described above, were plated in 35-mm Petri dishes in Easy Mega serum-free semisolid collagen medium (Hemeris, France) containing BSA (1.5%), L-glutamine (2 mM), 2βmercaptoethanol (100 µM), pyruvic acid (0.1 mM), CaCl 2 (250 µM), lipid mix (4%), bovine pancreatic insulin (10 µg/ml), human transferrin (300 µg/ml), IL-3, granulocyte colonystimulating factor (G-CSF), and growth factors: rhEpo = 20 UI/ ml, rhIL-3 = 20 UI/ml, rhG-CSF = 100 UI/ml. The culture plates were incubated at 37 • C in humidified 5% CO 2 for 14 days and scored for burst-forming erythroid (BFU-E) and colonyforming granulocyte-macrophage (CFU-GM) colonies. Steroids were dissolved in ethanol and diluted in the culture medium prior to use to a maximum of 0.1% ethanol (final). The results are described as percent of control, which was taken as 100. A standard error was calculated for the average of six separate experiments and the Student's t test was used to assess significance.
HEL Cell Line Culture
Cells were grown in RPMI 1640 supplemented with 10% FCS, 100 units each of penicillin and streptomycin, and 2 mM glutamine. The flasks were incubated at 37 • C under 5% humidified CO 2 atmosphere. To assess multiplication, 80,000 cells were transferred to 12-well tissue culture plates (6 per sample), exposed to the desired combination of steroids in ethanol (1% final) in a serum-free medium for 3 days, and finally counted manually with the aid of a hematocytometer (Blagosklonny and Neckers 1994) .
Immunocytochemistry
Two-hundred-microliter aliquots of the cell culture (1 million cells/ml) were cytospun and fixed with 3% formaldehyde plus 2% sucrose in PBS at 37 • C for 10 minutes, followed by permeabilisation in 20 mM Hepes, pH 7.4, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl 2 , and 1% NP40 at room temperature for 30 minutes, and finally washed with PBS. Nonspecific binding was eliminated by exposure to 5% fat-free milk (Regilait) for 15 minutes. Cells were thereafter flooded with 1:200 dilution of an antiserum directed against either the MCR or the alpha subunit of the epithelial sodium channel (αENaC) for 2 hours at 37 • C, followed by tetramethyl rhodanine isothiocyanate (TRITC)-conjugated antibody diluted 1/200 Mirshahi et al. 2000a Mirshahi et al. , 2001 . Confocal microscopy was carried out using a Zeiss LSM510 instrument (Mirshahi et al. 2000b) .
Analysis by PCR
RNA was prepared according to the protocol of Trizol Reagent (Gibco BRL) as described in our previous studies Mirshahi et al. 2000a Mirshahi et al. , 2001 . The polymerase chain reaction (PCR) for the MCR was performed with the aid of the
FIGURE 1
Analysis of megacaryoblastic progenitor cell separation by FACS. Bone marrow cells exhibit predominantly the CD34 + cells markers (A). FACS analysis of the purified CD34 + and CD41 + cells exhibited near total homogeneity (A). After 9 days in culture, the presence of CD41 + phenotype was evident in cells both before (B) and after (C) MACS purification.
primers 5 -AGGCTACCACAGTCTCCCTG-3 (sense) and 5 -GCAGTGTAAAATCTCCAGTC-3 (antisense) synthesized by Genosys (U.K.). The αENaC was similarly analyzed with the aid of the primers 5 -CTGCCTTTATGGATGATGGT-3 (sense) and 5 -GTTCAGCTCGAAGAAGA-3 (antisense), as described before (Mirshahi et al. 2000b) . Techniques for the preparation of polyclonal antibodies to the MCR (Mirshahi et al. 1992 ) and the peptide QGLGKGD-KREEQGL (region 44 to 57 of the αENaC cloned from rat colon) linked to keyhole limped hemocyanin (KLH) ) have been described as referenced.
RESULTS
Data in Figure 1 show fluorescence-activated cell sorting (FACS) analysis of cells isolated from human bone marrow by the MACS procedure. Both the CD34 + pluripotent cell and its clonogenic derivative CD41 + were revealed as homogeneous preparations that appeared suitable for further cellular and molecular analysis.
PCR analysis of total RNA revealed the presence of mRNA for the MCR and αENaC as predicted bands of 843 bp and 520 bp, respectively, in megacaryoblastic CD41 + cells isolated from human bone marrow, but platelets were negative for these genes (Figure 2A ). Human erythroblastic leukemia is a cancerous derivative of the megcaryocyte lineage. The PCR product of
FIGURE 2
The megacaryoblastic cells express both the MCR and the αENaC genes. Electrophoresis of the PCR products using mRNA from megacaryoblastic cells (A) was resolved into the predicted bands of 520 bp (b) and 843 bp (c), for the αENaC and the MCR, respectively, whereas platelets were negative for both genes (d, e). The HEL cell line (B) also expressed the mRNA for both the αENaC (f ) and the MCR (g).
total RNA from the human erythromegakaryoblastic leukemia (HEL) cell line was similarly resolved as predicted bands of 843 bp and 520 bp for the MCR and the αENaC, respectively, on agarose gels ( Figure 2B ). These data suggest that the MCR and the ENaC genes, present in the pluripotent megacaryoblastic CD41 + cells of the hematopoietic lineage, are not silenced by the abnormal differentiation into the HEL, but are permanently switched off as a result of normal differentiation into
FIGURE 3
Immunocytochemical localization of the MCR and the αENaC in megacaryoblastic cell derivatives. In immunoflurorescence developed with the aid of specific antibodies, the MCR was revealed as a nucleocytoplasmic protein (a) whereas αENaC was primarily membrane-bound (b) in the pluripotent megacaryocyte. The HEL lineage was similarly positive for the MCR (d) and
the αENaC (e). The corresponding controls for the MCR and the αENaC are presented in (c) and ( f ), respectively.
platelets. The amino acid sequence deduced from PCR products of HEL mRNA revealed 100% homology with the MCR in the N-terminal domain (residues 24 to 260) of the human kidney MCR gene. The αENaC gene in the HEL also exhibited almost 100% homology with the C-terminal domain (residues 388 to 528) of human kidney gene. Paucity of material did not permit similar sequence analysis in the megacaryoblastic CD41 + cells. Collectively, the MCR and the ASSC gene products in the hematopoietic cell lineage appear structurally similar to the proteins in endothelial cells ), fibroblasts , and epithelial cells (Garty and Palmer 1997; MacKnight, DiBona, and Leaf 1980) . Immunofluorescence revealed the presence of the MCR and αENaC as nuclear and membrane-bound proteins, respectively, in megacaryoblastic CD41 + cells purified from human bone marrow (Figure 3a, b) but platelets were negative under these conditions (not shown). The HEL cultures were similarly positive for the MCR and the αENaC proteins (Figure 3d, e) . Because the MCR and the αENaC genes are transcribed and translated in cells of the megacaryoblastic progenitor lineage, these
FIGURE 4
Bone marrow CD34 + cells thrive normally in the presence of steroids targeted for spcificity to the MCR. Bone marrow cells were grown in the MV 2 medium and exposed to 10 µM of either aldosterone (A), ZK 91587 (B), the two together (C), or ethanol alone (D). After 1 week, the cultures were analyzed for cell number, viability, and morphology. No significant differences were observed in the presence of steroids compared to the control.
cells should respond to steroids targeted for specificity to the MCR. The growth and multiplication of bone marrow CD34 + cells grown in the nonselective MV2 kit were not influenced by 10 µM of either aldosteone ( Figure 4A ), ZK 91587 ( Figure 4B ), or the two steroids combined together ( Figure 4C ), compared to the control ( Figure 4D ). No toxic effects were observed on total cell number, viability, and morphology (Figure 4) in the presence of either steroid, albeit ZK 91587 appeared to favor colony formation ( Figure 4B ), but this was not quantitated. In still other experiments, the exposure to ZK 91587 did not influence the viability of mononuclear cells purified from the bone marrow, thereby ruling out generalized toxicity (not shown). Collectively, the CD34 + cells appeared suitable for analyzing the effect of steroids on the differenciation and maturation of progenitors into committed cell lines and it was on this aspect that the attention was next focussed.
To this end, CD34 + cells from the peripheral blood were grown in media capable of selecting various cell lineages ( Figure 5 ). When CD34 + were analyzed for BFU-E ( Figure 5A ), the number of colonies was significantly decreased over control ( p < .006) in the presence of 10 µM deoxycorticosterone, although this steroid is a partial mineralocorticoid agonist in vivo (Agarwal 1994; Agarwal and Mirshahi 1999) . The antagonists RU 28362 and ZK 91587 (10 µM) alone (not shown), or along with the agonist deoxycorticosterone, abolished the growth of CD34 + . Although aldosterone alone did not influence the proliferation of CD34 + cells, it significantly ( p < .001) reversed the inhibitory effect of the antagonist ZK 91587 ( Figure 5A) . When CFU-GM were considered ( Figure 5B ), ethanol was found to have a deleterious effect on colony formation, which was reversed by both deoxycorticosterone ( p < .014) and aldosterone ( p < .002). Both RU 28362 and ZK 91587, alone and in combination with the agonists, modified CFU-GM colony formation in a manner qualitatively similar to BFU-E ( Figure 5A) . The proliferation of HEL cells was significantly inhibited ( p < .001) by 10 µM deoxycorticosterone alone and this was not further exacerbated by the antagonist 10 µM ZK 91587, which did not influence cell proliferation at all ( Figure 5C ), in contrast to the situation with clonogenic stem cells (Figure A, B) . In other studies, ZK 91587 and aldosterone could exert either a positive or a negative effect on HEL cell multiplication, depending upon the dose of the steroid (Mirshahi et al. 2000b ). Thus, the effect of steroids, targeted for the MCR, depends upon the dose and the cell type and no generalizations appear possible.
DISCUSSION
The results described in this paper reveal a number of new and novel features of mineralocorticoid hormone action. The analysis by PCR shows unequivocally that both the αENaC and
FIGURE 5
Mineralotropic steroids alter the colony formation by hematopoietic cells. CD34 + cells from peripheral blood were grown in the presence of various combinations of agonists (aldosterone or DOC) and antagonists (RU 28362, ZK 91587) . The cultures were screened for either BFU-E (A) or CFU-GM (B). BFU-E decreased significantly with 10 µM DOC (b versus c, p < .006) and this was further potentiated by 10 µM of either RU 28362 (d) or ZK 91587 (e), both of which alone (not shown) also eliminated CFU. Aldosterone alone did not affect CFU (b versus f; NS), but ZK 91587 plus aldosterone led to significant decrease in total CFU (f versus g; p < .001).
With CFU-GM (B), ethanol was found to have a deleterious effect that was reversed by DOC (b versus c; p < .014) and aldosterone (b versus f; p < .002); otherwise, the results were qualitatively similar to those with BFU-E (A). The proliferation of leukemic HEL cells was significantly inhibited by 10 µM DOC alone (a versus c; p < .001) and this was not further exacerbated by 10 µM ZK91587, which, alone, did not influence cell proliferation at all (C), in contrast to the situation with the clonogenic stem cells (A, B) . NS = not significant.
the MCR genes are present in the pluripotent megacaryoblastic CD41 + lineage, as well as in the erythromegacaryoblastic leukemic cell line, and are transcribed into mRNA in a manner described before for a number of other epithelial and nonepithelial cell types (Agarwal et al. 1996; Mirshahi et al. 2000a Mirshahi et al. , 2000b . Thus, the PCR products were finally resolved as predicted bands of 843 bp and 520 bp for the MCR and αEnaC, respectively, as in previous studies with cells and tissues known to respond to the MCR (Agarwal et al. 1996; Mirshahi et al. 2000a Mirshahi et al. , 2000b . The amplification by a primer similar to that used in earlier studies suggests that the initiation sites for the MCR and ENaC are closely related in cells of diverse embryological origins (Agarwal et al. 1996; Mirshahi et al. 2000a Mirshahi et al. , 2000b . Sequence analysis of the nucleotide residues 1 to 778 in the PCR products revealed almost 100% homology with the residues between 2944 (5 end) and 2525 (3 end) of human kidney MCR gene, with only minor substitutions (data not shown). Similarly, the residues 1 to 495 of αENaC cDNA from megacaryocyctic CD41 + and HEL cells share almost 100% sequence homology with the residues 1187 to 1682 (colon) and residues 1170 to 1665 (lung) of the human ENaC gene (not shown). Interestingly, both the MCR and αENaC in the human megacaryoblastic CD41 + lineage are permanently silenced in the physiologically inert platelets in contrast to their continued expression in the leukemic state. In all of these cells, the MCR was readily recognized by an antibody directed against the rat kidney protein purified in the presence of RU 26752 that binds specifically to this receptor (Agarwal 1994; Agarwal and Mirshahi 1999; Mirshahi et al. 1992) . Immunocytochemistry demonstrated the presence of the MCR in the nucleocytoplasmic compartment of the megacaryoblastic CD41 + cells and HEL, much as in cells of other target organs (Agarwal et al. 1996; Mirshahi et al. 1992 Mirshahi et al. , 1999 Mirshahi et al. , 2000a Mirshahi et al. , 2000b . The immunofluorescence was restricted to the membrane in the megacaryoblastic CD41 + cell with the antibody directed against the apical sodium channel. In other studies, this subcellular localization was actually confirmed by confocal microscopy and forms an irrefutable proof for the predicted compartmentalization of these two proteins such that the expression of the membrane-bound sodium channel in the megacaryoblastic lineage (Mirshahi et al. 2000b ) may indeed be under the genomic control of mineralotropic steroids, as previously shown in cells of both the epithelial and the nonepithelial origins (Agarwal et al. 1996; Mirshahi et al. 2000a Mirshahi et al. , 2000b .
The modification of colony formation by CD34 + , and of HEL cell proliferation, by the MCR-specific, synthetic spirolactones (RU 28362, ZK 91587) clearly suggests the presence of functional MCR, much as in a number of other cell types (Mirshahi et al. 2000a ). The specificity of ZK 91587 for the MCR makes it very unlikely that the steroid may bind to different classes of receptors in the cell, or provoke generalized toxicity. Although aldosterone and deoxycorticosterone are classically described as MCR agonists in vivo, and RU 28362 and ZK 91587 are potent antagonists (reviews in Agarwal 1994; Agarwal and Mirshahi 1999) , the effect of these steroids in the HEL cell line did not follow these established criteria, supporting other studies on endothelial cells ) and fibroblasts . The reason(s) for these differences are not understood, but mineralocorticoid signaling may nevertheless form an exploitable target for the control of cell proliferation in cancer. Because both the MCR and the ENaC genes appear to be expressed as early as the CD34 + stage, the effect of minearlocorticoids could well proceed by the MCR-mediated effect on the ENaC. Modified ionic flux is known to stimulate cell proliferation along considerable distances in the kidney (Stanton and Kaisling 1989 ) and a similar mechanism may underlie the effect of mineralocorticoids (Spach and Streeten 1964) . Consequently, the erythropoietic cell lineage may form a new and novel model to elucidate various aspects of the action of mineralocorticoids (Krause, Fackler, and Civin 1996; Nilius and Droogmans 2001) , contrary to earlier suggestions where this property would be attributed exclusively to the epithelial cell (Garty and Palmer 1997; MacKnight, DiBona, and Leaf 1980) . Because the hematopoietic differentiation is regulated by a number of different genetic switches (Fuchs and Segre 2000; Smithgall 1998 ), steroids could conceivably alter some of these parameters as well, thereby providing entirely new and unexplored opportunities for further insight into the mechanism of receptor-mediated mineralocorticoid hormone action, as previously postulated for glucocorticoids (Wessely et al. 1997 ) and gonadal steroids (Blagosklonny and Neckers 1994) . Finally, these steroids also exhibit some potential as growth factors for the large scale production of normal cells for human transfusion.
